Charlotte George, DPM
Foot & Ankle Surgery · Enfield, CTNPI 1417486044
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,428 of the $1,635 with a category attached, or 87.4%. Stryker accounts for 63.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $778 and has fallen 80.7% since, to $150 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in CT, where the typical reported total is $1,838.
Across 33 payments — averaging $49.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Smith+Nephew$153
- Zimvie Inc.$136
- Davol Inc.$98
- Axogen$74
- Purelife, LLC$50
- plus $91 from 4 others
What the payments were for
- Food & beverage$1,42887%
- Education$15710%
- Gifts$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,034 |
| Smith+Nephew | 8 | $153 |
| Zimvie Inc. | 2 | $136 |
| Davol Inc. | 1 | $98 |
| Axogen | 1 | $74 |
| Purelife, LLC | 1 | $50 |
| Bioventus LLC | 2 | $33 |
| Amgen | 1 | $24 |
| Hydrofera LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CITREFIX$257
- AUGMENT INJECTABLE$150
- HOFFMANN$113
How this compares
$1,635 in reported general payments places this provider in the 45th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 29 | $30,934 |
| Ciclopirox | 63 | $2,088 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $1,210 |
| Ketoconazole | 45 | $835 |
| Pregabalin | 15 | $472 |
| Doxycycline Monohydrate | 38 | $378 |
| Terbinafine Hcl | 12 | $240 |
| Silver Sulfadiazine | 38 | $191 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $159 |
| Methylprednisolone | 21 | $150 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $123 |
| Doxycycline Hyclate | 11 | $81 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $73 |
| Meloxicam | 12 | $34 |
| Prednisone | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Enfield
- Thomas McDonaldEnfield$241K
- Matthew TschudyEnfield$4K
- Kristen WintersEnfield$3K
- Rebecca WiesnerEnfield$3K
- Kayla O MalleyEnfield$2K
- Elizabeth SchwartzEnfield$1K
- Laura Vander PoelEnfield$812
- Thomas JohnsonEnfield$683
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.